The Complexity of Cold Chain Logistics

September 08, 2016

Cell and gene therapy is now considered “the third pillar” of health care — along with traditional pharmaceuticals and biologic drugs. One critical challenge in the commercialization of cell and gene therapies is the complex logistics required for their handling. Any delay or temperature excursion can jeopardize the quality of these materials and, ultimately, the results of the clinical trial. In a recent article in Contract Pharma, Mark W. Sawicki, Ph.D., chief commercial officer of Cryoport, discusses how success in the clinical trial process depends upon a strategic logistics plan that includes packaging, transport, storage and handling support. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Cold Chain, Temperature Controlled Logistics, Frozen Biological Shipping